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hepatotoxicity via nuclear factor kappa- β
Abdulrahman L Al-Malki1* and Ahmed Amir Radwan Sayed1,2Abstract
Background: Cisplatin (CP) is known as a potent anti-cancer drug. The most therapeutic adverse effect of CP is
induced hepatotoxicity. In the present study, the protective effect of thymoquinone (TQ) on CP-induced
hepatotoxicity was studied.
Methods: Wistar rats were divided into three groups (15 rats each). Group 1 served as the control group. Group 2
rats were injected ip with a single dose of CP (12 mg/kg b.w, i.p.). Group 3 rats were orally pre-treated with TQ
(500 mg. kg−1. day−1) for one month, then the animals were injected i.p with CP 12 mg.kg−1.
Results: The beneficial effects of TQ with its antioxidant/anti-inflammatory effects were observed. Injection of rats with CP
markedly affected the liver functions and histopathological changes. The antioxidant enzyme activities and reduced
glutathione (GSH) contents were significantly decreased while the levels of malondialdehyde (MDA) significantly increased.
The electromobility shift assay (EMSA) showed a significant activation of NF-κB-p65 in the rat liver injected with CP.
Furthermore, the expression and concentrations of inflammatory tumor necrosis factor (TNF-α), nitric oxide synthetase
(iNOS), and interleukin (IL-1β) were markedly elevated in the CP injected rats. The administration of TQ improved all the
altered functions, histopathology of the liver and attenuated the activated NF-κB. The antioxidant enzyme activities
(glutathione peroxidase and glutathione –S transferase) of the rat livers were markedly increased while MDA was
reduced as a result of TQ administration. In addition, the expression of TNF-α, iNOS, and IL-1β were markedly reduced.
Conclusion: It was concluded that, TQ has potential benefits in the prevention of the onset and progression of CP
induced hepatotoxicity.
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The modern life style and environmental pollution, have
been the causes of increased cancer burdens in the world.
Chemotherapy is one of the most important methods used
in cancer therapy. CP [cis-diamminedichloroplatinum (II)]
(CP) is a well known anticancer drug. It is primarily used
as a drug in the treatment of solid tumors. Use of CP in
the treatment of tumors is restricted due to its toxic effect
on kidney and liver, which can be seen after a single dose
of CP in approximately 28% to 36% of cancer patients [1].
CP is a small molecule which can easily cross the plasma
membrane and then to nucleus. In the nucleus, CP causes
changes in the structure of the DNA molecule. These
changes result from the formation of inter- and intra-* Correspondence: alalmalki@kau.edu.sa
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article, unless otherwise stated.chain adducts between CP and the nitrogen bases of the
DNA [2]. Oxidative stress plays the key role in the CP in-
duced hepatotoxicity. Previous studies showed that, the
earliest signs of CP induced hepato-toxicity are the fall in
the hepatic reduced glutathione (GSH) levels and an in-
crease in the hepatic malondialdehyde (MDA) levels [3].
These signs indicate the acceleration of the peroxidative
processes in the hepatic cell [4,5].
The oxidative stress and production of reactive oxygen
species (ROS) such as hydroxyl radicals, superoxide anions,
and hydrogen peroxide are normally generated in liver. A
detoxification mechanism working in the liver detoxifies
the ROS by endogenous antioxidants such as GSH, SOD,
and catalase. The accumulation of intracellular ROS leads
to an increase in both DNA damage and peroxidation of
membrane lipids [4].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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from different factors such as pollution of water and air
and radiation exposure. Further, endogenous free radical
production results from normal metabolism. Many chronic
diseases, like cancer, diabetes, Alzheimer, and cardiovascu-
lar diseases are associated with free radical production.
Free radicals are highly reactive intermediates. They react
with nucleotides of DNA, the sulphhydryl bonds of pro-
tein, and the polyunsaturated fatty acids found in cellular
membranes that result in tissue damage [6]. Prevention
and/or decreasing of the side effects of CP are of the main
concerns in treating patients suffering from cancer. Differ-
ent methods were established to attenuate the toxic effects
of CP, such as combination of the free radical scavengers
[7] but it is not efficient.
Thymoquinone (TQ) is a phytochemical that has been re-
ported to exhibit antimicrobial effects against different spe-
cies of bacteria. TQ is considered as potent anti-oxidant,
anti-carcinogenic and anti-mutagenic agent. Moreover,
TQ is a relatively safe compound, particularly when given
orally to experimental animals [8].
TQ is a quinone isolated from Nigella sativa seeds. Pre-
vious study showed that TQ has a significant protective
action toward an array of free radical creating com-
pounds like doxorubicin [9]. In addition TQ has an anti-
inflammatory as well as an analgesic action and protects
against carcinogenesis induced by different chemical com-
pounds [10]. Moreover, TQ has protective effect against
both diabetic nephropathy [11-13] and membrane in-
duced lipid peroxidation [8]. Furthermore, it has been
showed that TQ is a potent suppressor of iron-NTA
induced oxidative stress and carcinogenesis in the rat
kidney [14].
The aim of the present study is to evaluate the pro-
tective effects of TQ on the CP-induced hepatotoxicity
in rats. In addition, the mechanism of action of TQ was
studied to show the impact of oxidative stress as well as




Thymoqunione (TQ) was purchased from Sigma-Aldrich
(St. Louis, MO, USA). BCA mega kit (Pierce, Rockford,
USA). All assay kits were obtained from BIORAD (England).
Primers were obtained from Bioline Inc., (Taunton, MA,
USA). Monoclonal antibody, anti- NFkBp were obtained
from Bioline Inc. All the chemicals used in the study were
of analytical grade.
Animals
Male Wister rats weighting 190 ± 30 g were kept for
7 days with free access to water ad libitum and standard
rat chow.All the animal protocol was approved from the University
Animal Ethics committee. CEGMR committee licensee #
at KASCT. HA-02 J-003.
Rats were randomly divided into three groups each
consists of 15 rats. Group 1 served as the normal control
group. Animals of this group were treated with normal
saline intrapertoneal (ip). Group 2 was injected i.p. with
a single dose of CP (12 mg/kg b.w, i.p.) obtained from
Sigma (England). Group 3 was orally pre-treated with
TQ in polypropylene glycol (500 mg. kg−1. day−1) [12]
for one month, then the animals were injected i.p. with
CP 12 mg.kg−1 body weight [15]. TQ treatment was con-
tinued for one month. At the end of the experiment, rats
were sacrificed, the blood was collected, and serum was
separated and stored at −80°C. Serum was used for the
determination of serum lactate dehydrogenase (LDH),
alanine amino transferase (ALT), γGGT, aspartate amino
transferase (AST), total protein (t. Protein) alkaline
phosphatase (ALP), albumin, and total bilirubin.
Liver was isolated and rinsed carefully with cold normal
saline and divided into four parts. The first part was used
to prepare the tissue homogenate in phosphate buffered
saline (50 mmol/l, pH 7). The liver homogenate was used
for the assay of the activity of superoxide dismutase
(SOD), catalase, glutathione peroxidase (GSH-Px), gluta-
thione S transferase (GST), and the levels of reduced gluta-
thione (GSH), malondialdehyde (MDA), NO, IL-1β and
TNFα. The second part of the liver was used in the prepar-
ation of the tissue extract for electromobility shift assay
(EMSA) analysis. Total RNA was extracted from the third
part of the liver and the fourth part was used for histo-
pathological examinations.
Assay of ALT, AST, ALP, t. protein, albumin, t. bilirubin,
and γGGT
ALT, ALP, AST, albumin, t. protein, γGGT and t. biliru-
bin in the serum of all rats were assayed using the avail-
able kits obtained from Bio Vision Research Products
(Avenue, USA). All assays were made according to the
instructions of the manufacturer.
Determination of LDH
The method of King [16] was used for the assay of LDH
using kit from BIORAD (England).
Assay of reduced GSH
Reduced GSH was assayed by the colorimetric end point
method as described by Sayed [17] using kit from BIORAD
(England).
Determination of the activity of glutathione peroxidase
The method of Paglia and Valentine [18] was used for the
determination of the activity of glutathione peroxidase in
Table 1 Biochemical parameters of liver function tests as
well as initial and final body weights of rat
Group 1 Group 2 Group 3
Initial body weight, g 210 ± 10 203 ± 12 201 ± 12
Final body weight, g 243 ± 18 172 ± 12a 225 ± 12b
ALT, U/L 29.12 ± 1.12 98.32 ± 2.3a 39.2 ± 1.3
AST, U/L 26.78 ± 1.5 90.78 ± 1.14a 48.5 ± 5.3
ALP, U/L 167.34 ± 2.32 369.12 ± 18.8a 215.3 ± 11.2b
LDH, U/L 75.67 ± 2.12 155.56 ± 2.4a 112 ± 4.2b
γGGT, U/L 59.36 ± 1.45 109.5 ± 2.43a 85 ± 3.5
t. protein, mg% 9.53 ± 0.76 6.15 ± 1.27 6.8 ± 2.1
Albumin, mg% 3.94 ± 0.98 2.4 ± 0.54a 4.65 ± 2.5b
t. Bilirubin, mg% 0.75 ± 0.05 1.6 ± 0.23a 1.1 ± 0.01b
Values are expressed as mean ± S.D. of triplicate tests (n = 15).
aP < 0.05 vs group1, bP < 0.05 vs group 2.
The effect of TQ on the liver function parameters of different groups.
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The activity was expressed as U/mg protein.
Assay of GST activity
The activity of GST was determined as described by
Moron et al. [19] by using 1-chloro −2, 4- dinitro ben-
zene (CDNB) as an electrophilic substrate using kit from
BIORAD (England). The activity was expressed as nmol/
mg protein.
Assay of malondialdehyde (MDA)
Malondialdehyde (MDA) was assayed using the method
described [20,21]. The concentration of MDA was calcu-
lated and expressed as nmol . mg−1 protein.
Assay of the activity of SOD
The activity of super oxide dismutase was assayed as
described [22] using kit from BIORAD (England). The
activity was expressed as U/mg protein.
Assay of the nitric oxide concentration
The formation of NO was determined by indirect method
by quantifying the tissue level of nitrite by a calorimetric
method by Griess reaction [23] using kit from BIORAD
(England).
Assay of IL-1β and TNF-α
IL-1β and TNF-α levels were assayed using an available
ELISA kit from R & D (Berlin, Germany) according to
the manufacturer’s instructions [24]. Protein concentra-
tion in the liver homogenate was assayed using BCA
mega kit (Pierce, Rockford, USA).
RT-PCR
The transcripts were amplified in a single reaction con-
taining 1 mg cDNA and 0.5 mM each of the sense and
antisense primers for IL-1β ( sense 5′- AT GG CA AC
TG TC CC TG AA CT C -3′; antisense 5′- GT CG TT
GC TT GT CT CT CC TTG -3′ ), TNFα sense 5′-
TCATGCACCACCATCAAGGA-3′ and antisense 5′-
GA CA TT CG AG GC TC CA GT GA A -3′ and iNOS
sense 5′-CA GC CA AG TATT CC AA AG CA A −3′ and
antisense 5′- AG TC CA GT CC CC TC AC CA A −3′;
β- actin sens 5′ GT GC TA TG TT GC TC TA GA CT
TC G −3′, antisens 5′ AT GC CA CA GG AT TC CA TA
CC −3′ were obtained from BIOLINE Inc., (Taunton,
MA, USA).
The cycle consistes of preheating step at 95°C for 5 mi-
nute followed by 35 cycles of 90°C for 1 minute, and
60°C for 30 seconds.
EMSA analysis
Part of the liver was dissolved in TOTEX buffer. The ex-
tract was used for determination of the binding activityusing NF-κBp65 consensus sequence: 5′-AG TT GA GG
GG AC TT TC CC AG GC -3′ which was obtained from
BIOLINE Inc. (Taunton, MA, USA). The increase in the ex-
pression of NFkBp65 gene was determined by a Phosphor
Imager using background subtraction [25].
Histopathological examination
Liver tissues were collected from rats, washed carefully
by cold normal saline 3 times, then fixed in formalin so-
lution 10%, processed, and embedded in a paraffin film.
Sections of 5-μm thick slices of liver were prepared. The
sections were stained with H & E. The method was de-
scribed in Fukuzawa et al. [26].
Immunohistochemistry
The sections of tissues in phosphate-buffered saline
(pH = 7.2) were incubated overnight at 4°C with the re-
spective primary monoclonal antibody, and anti- NFkBp
dilutions (1:100, 1:50). Immunohistochemical staining was
performed by the streptavidin-biotin complex method. All
sections were then counterstained with hematoxylin.
Statistical analysis
All values are expressed as the mean ± SD. Data were eval-
uated by using SPSS for windows. The one way ANOVA
test was used to examine whether there are any significant
differences between the treatment groups, and the value
of P < 0.05 was considered significant.
Results
Initial and final body weights
Both the initial and the final body weights of all rats are
presented in Table 1. There were no significant differences
in the initial body weights among all three groups. Rats
treated with CP (group 2) showed a significant decrease in
the final body weights (group 2) when compared to the
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group 3 showed a significant increase in the final body.
Effect of CP and TQ administration on the hepatic
biomarkers
Table 1 shows that the injection of CP significantly in-
creased the hepatic levels of ALT, ALP, AST, γGGT, total
bilirubin and LDH and a significant decrease of serum
albumin when compared to the control group. Adminis-
tration of TQ significantly improved the negative effects
of some of the hepatic biomarkers and modulated the
other toxic effects.
Effect of TQ administration on glutathione peroxidase
activity
As a result of CP treatment, the activity of GSH-px in
the liver tissue of the rats in group 2 was significantly re-
duced when compared with the control group (group 1)
(Table 2). On the other hand, treatment of rats in group
3 with TQ resulted in a marked increase of GSH-px ac-
tivity when compared to the CP treated rats (group 2)
(P < 0.05).
Effect of TQ administration on superoxide dismutase
activity
SOD plays an important role in detoxification of the hy-
droxyl radicals. The activity of SOD in the liver homoge-
nates of all experimental rats is shown in Table 2. In
group 2, treatment of rats with CP reduced the SOD ac-
tivity compared to the control group. Enhancement of
SOD activity was observed as a result of TQ treatment,
and the activity was found to be markedly increased.
Effect of administration of TQ on glutathione-S-transferase
activity
Table 2 shows a significant decrease in the hepatic GST
activity upon CP treatment as compared to the control
group (P < 0.05). A significant increase in GST activity
was observed in the rat group treated with TQ as com-
pared to the CP treated group (P < 0.05).Table 2 Antioxidant parameters of rat liver
Group 1 Group 2 Group 3
MDA, nmol/mg protein 0.52 ± 0.06 5.1 ± 0.85a 0.95 ± 0.02b
GSH, nmol/mg protein 111 ± 5.8 55.9 ± 4.6a 89.5 ± 2.1b
GST, nmol/mg protein 18.6 ± 1.5 6.29 ± 0.39a 14.76 ± 0.86b
SOD, U/mg protein 15.8 ± 1.1 9.6 ± 2.1a 14.25 ± 1.1b
CAT, U/mg protein 5.95 ± 0.5 2.41 ± 0.31a 4.56 ± 0.54b
GSH-Px, U/mg protein 4.95 ± 0.21 2.05 ± 0.12a 4.67 ± 0.65b
The expressed values are mean ± S.D. of triplicate tests (n = 15).
aP < 0.05 vs group1, bP < 0.05 vs group 2.
The activity of the antioxidant enzymes as well as the levels of MDA and GSH
in the liver homogenates of different groups.Effect of TQ administration on glutathione levels
CP treatment significantly decreased GSH level in the liver
tissue homogenates compared to the control group. Rats
treated with CP had a lower GSH content than the normal
control group. Administration of TQ significantly modu-
lated these alterations and the level of GSH rose (P < 0.05)
as shown in Table 2.
Effect of administration of TQ on lipid peroxidation
Formation of free radicals and induction of oxidative
stress is a direct cause of lipid peroxidation. Lipid peroxi-
dation was measured as MDA in rat liver homogenate
and the results are shown in Table 2. After 12 mg/kg CP
injection, the liver MDA level significantly increased. Ad-
ministration of TQ significantly decreased the amount of
MDA in the CP treated rats of group 3. The oral adminis-
tration of TQ decreased the level of MDA.
Effect administration of TQ on catalase activity
As a result of CP injection, catalase activity was markedly
reduced. Table 2 shows that the activity of catalase was re-
duced in the CP treated group. However, the oral adminis-
tration of TQ increased the activities.
Effect of CP and TQ treatment on NO, TNFα and IL-1β
The effect of CP as well as the effect of TQ on NO, TNFα
and IL-1β in rats was studied. Figure 1 shows that the
level of NO was markedly and dose dependently increased
as a result of CP treatment. Administration of TQ re-
versed these effects and significantly reduced the levels of
NO in the treatment group 3 (Figure 1A).
The levels of TNFα and IL-1β were significantly and
dose dependently elevated in the CP treated rats (group 2)
as indicated in Figure 1B and C. The elevated levels of
TNFα and IL-1β were significantly reduced as a result of
TQ administration.
NF-κB-p65 was markedly activated in the CP treated
animals compared with the control. Administration of
TQ resulted in a significant reduction in the of NF-κB-
p65 in a dose dependent manner (Figure 2).
As a result of oxidative stress, NF-κB-p65 was markedly
activated in the cisplatin treated animals compared with
the normal control. Administration of TQ resulted in a
significant reduction of the of NF-κB-p65 activation. The
levels of TNFα and IL-1β were significantly and dose de-
pendently elevated in the CP treated rats (group 2) as in-
dicated in Figure 1B and C. The elevated levels of TNFα
and IL-1β were significantly reduced as a result of TQ ad-
ministration (Figure 3).
Rats which received cisplatin showed a significant in-
crease in the immunoreactivity of NF-κB in the cytoplasm
of hepatocytes compared with the normal control group.
On the other hand, thymoquinone-treated rats showed
considerable reduction in the cisplatin-induced expression
Figure 1 Effect of TQ on the levels of nitric oxide (A), IL1-β (B), and TNFα (C) of CP treated rats. Results are presented as mean ± SD,
*P < 0.05 against group 1, **P < 0.05 against group 2.
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rats group 2 (Figure 4D-F).
Discussion
Thymoquinone (TQ) showed diverse therapeutic benefits
as related to bronchial asthma, dysentery, headache, gastro-
intestinal problems, eczema, hypertension, and obesity,
antiproliferative effects on cell lines derived from breast,Figure 2 Binding activity of NF- κB. Quantification of activated NF-kB wa
Results are the means ± SE of four individual replicates; value from an unpaire
comparing with group 2.colon, ovarian, larynx, lung, myeloblastic leukemia, and
osteosarcoma. Mechanistically, TQ induced apoptosis in
tumor cells by suppressing NF-κB, Akt activation, and
extracellular signal-regulated kinase signaling pathways
and also suppress tumor angiogenesis. These studies sug-
gested that TQ is useful as conventional chemotherapeu-
tics against cisplatin induced cytotoxicity. It was found
that, TQ was effective as inducer of apoptosis in somes performed by densitometric analysis of relative EMSA band intensities.
d Student’s t-test (*P < 0.05, compared with group 1 and **P < 0.001)
Figure 3 Effect of CP on IL1-β, TNF-α and iNOS expression (A). The relative intensity of the bands is represented in (B) Data are the mean ± S.D.
(n15); *P < 0.01, **P < 0.01 vs. control animals.
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proteins such as Bcl-xL [9].
The hepatic cell contains high levels of transaminases
as AST. As a result of the damage caused to hepatic cells
by CP, the leakage of cytosol resulted in increasing levels
of the liver specific enzymes in the rat serum. The ele-
vated levels of the hepatic enzymes in the serum such as
AST and ALT are markers that indicate the cellular leak-
age and the functional integrity of the liver cell mem-
brane [27]. The serum levels of ALT and AST serve as a
indirect assessment of the condition of the liver. In the
present study, the capability of TQ in ameliorating the
CP-induced hepatotoxicity was observed in that the rats
of group 3 had lower levels of the hepatic enzyme in the
serum when compared with the animals of group 2.
TNF-α is a pro-inflammatory cytokine. Its levels are ele-
vated in the acute and chronic disease conditions. The
anti-inflammatory action of TQ was estimated in vivo byFigure 4 Histopathological and immunohistochemical observation of
hepatocellular necrosis (complete arrows) are displayed). (A): Control
with thymoquinone then cisplatin as discussed in methods. Immunohistoc
expression of NF-κB; (E, 200) group 2 showing a significant increase in NF-κ
group 3 demonstrating a significant reduction in NF-κB immunostaining.measuring the release of TNF-α. Previous studies showed
that natural products have the ability to reduce inflamma-
tion by blocking the inflammatory mechanisms down-
stream of the release of cytokines, and also by attenuating
the production of the proinflammatory factors by macro-
phage [28]. It was reported that the proinflammatory cyto-
kines like TNF-α play an important role in the pathogenesis
of a large number of liver diseases. TNF-α is released from
the activated Kupffer cells. Following its release, it aggra-
vates both the inflammatory response and oxidative stress
in the hepatic cells [29]. In addition, it induces the pro-
duction and release of chemokines and cytokines from
macrophages and stimulates phagocyte nitric oxide (NO)
production and oxidative metabolism. Although previous
studies showed that the production of NO protects the
liver from injury by a NOS inhibitor, recent data shows
that the excessive production of nitric oxide by iNOS can
result in hepatic injury [30]. A recent report showed thatrat liver sections Vacuolar degeneration (dotted arrows) and
group; (B): group treated 12 mg/kg cisplatin; (C): group pretreated
hemical staining of NF-κB in rat from: (D, 200) group 1, showing no
B immunoreactivity in the cytoplasm of hepatocytes; and (F, 200)
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the acute liver injury. This suggested that iNOS could act
as a mediator in the pathogenesis of the liver toxicity in
rats [31].
In this study, we showed that the liver protective effect
of TQ was not only attributed to its inhibitory effect on
the release of the inflammatory mediators NO, TNF-α,
and IL-1β, but also to its antioxidant properties. MDA, a
product of lipid peroxidation, was increased in the rat
liver as a result of CP injection. However, we showed
that TQ significantly reduced MDA formation. In other
words, the mechanism of the inhibitory effects, by which
TQ protects against lipid peroxidation, may involve rad-
ical scavenging capability. Hepatotoxicity not only initi-
ates lipid peroxidation but also reduces tissue GSH-px,
GST, CAT, and SOD activities, and this depletion may
result from oxidative modification of these proteins and
our data are in line with other previous studies [32-36].
NF-κB is a nuclear transcription factor found in the
cytoplasm of the liver cells. In the cytoplasm, it binds to
its inhibitory subunit I-κB. As a result of oxidative stress,
NFκB is activated and phosphorylated from its inhibitory
subunit. As a result of its activation, NF-κB transfers to
the nucleus of the hepatic cell, binds to DNA and up-
regulates the transcription of many inflammatory genes
like cytokine, chemokine and receptors of advanced gly-
cation end products [31]. Our data from the EMSA and
immunohistochemistry showed a marked activation of
NF-κB which are in line with the hypothesis above. In
addition the data on the levels of TNF-α, NO and IL-1β
and the expression of the TNF-α, iNOS and IL-1β genes
support the results of the EMSA and immunohisto-
chemistry. Our study is in accordance with the study
that reported that TQ induced apoptosis in tumor cells
by suppressing NF-κB, Akt activation, and extracellular
signal-regulated kinase signaling pathways and suppress-
ing tumor angiogenesis. These studies suggested that
TQ is useful as conventional chemotherapeutics against
cisplatin induced cytotoxicity. It was found that TQ was
effective as inducer of apoptosis in some types of cancer
by down-regulating several antiapoptotic proteins such
as Bcl-xL. For this reason black Nigella seeds is widely
used in baking of bread and other foods, as additive for
spiced and flavored and aromatic substances. Nigella
seeds are reported as antifungal, antibacterial, antiviral
and antihelmintic, treatment of flatulence and abdominal
ailments, decrease fasting plasma glucose concentration
in rabbit, increase serum total protein, as diuretic, hepa-
toprotective and hypotensive.
The present study clearly demonstrates that control-
ling of oxidative stress and catalytic reactive oxygen scav-
enging are effective in the prevention of CP induced
hepatotoxicity. TQ is the major constituent of the natural
food supplement (Nigella sativa) with a broad spectrumof beneficial biochemical and cellular biological effects,
based on its ability to reduce inflammation and ROS over-
production. Since TQ also has beneficial effects on other
target tissues and shows beneficial effects of mediators of
large vessel damage, this mechanism appears attractive for
the prevention or delay of many disorders.
Conclusion
Our findings show that TQ has the potential benefits in
the prevention of the onset and progression of CP in-
duced hepatotoxicity.
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